Member Info for Tyke68

Max

Yes, Good news equals a sp normally

Thanks

Well that’s not good a start to the day. Do they know something or are they just guessing what the annual results will be?

Thanks

Mornington Oz

We are all just waiting for the end of year results and the GaM trial data being published. We will then either celebrate or cry.

Hopefully at some point it starts fulfilling its potential. However, for that to happen the company needs to admit to previous mistakes and how to correct them going forward.

Or just sell to the highest bidder.

Thanks

Cheers Max

I would say very ironic. We have people who can create world leading tech, it is just a pity they don’t seem to have people who understand why they struggle with sales.

Thanks

Thanks Max

It doesn’t say where they will be doing this training. Will it be on twitter, YouTube, webinar etc? No links to sign up etc. Yet again the communication is terrible. Can they not learn to explain things clearly and engage with prospective customers etc?

I wonder if they have done an email campaign to prospective users. The 40ish institutions mentioned a few years ago would be a good start. We seem to just use twitter. Pay for an advert as we have discussed previously. They need to create some traction and get people told and then buying our products.

If they can’t do it then sell the technology to a bigger company that can.

Let’s see what revenue last year was or if they have seen a significant increase since Mike has focussed fully on this not GaM.

Thanks (sort of rant over)

Malletp

It might be worth telling the company this as their website https://imagingbiometrics.com/cpt-codes/ just talk about the ready to go codes. Are we missing an opportunity, who knows?

Thanks

Unfortunately Theseawolf the new modus operandi seems to mean less information. It will be interesting to see if Xviolet hears back from the company.

We could all be positive and think how good the end of year might be. We should if the last RNS were to be believed now be making a profit. It is just a shame the ASCO award and EAF151 trial haven’t be turned into major revenue streams (yet).

With regards the GAM data, we honestly don’t know what is happening, the data hasn’t been published yet. Everybody from MCW seem to quote it in their new clinical trials but that is no good to us unless we are fully recompensed for the data.

I honestly think the best thing for LTH would be a bigger company or two buys the tech side and/or the clinical trial data. Plus the sale is at a price to represent the true value of both sides of the company.

Thanks/good luck

Max

When you are back from your holiday a puzzle for you. The ASCO can you find where KS is presenting the results on this agenda?https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/program-guide/scheduled-sessions

I can find one by Michael Veronesi from MCW about Radiation Necrosis but nothing about GBM’s. Probably me being useless as normal.

Thanks

Xviolet

Thanks, unfortunately we don’t get as many replies as we used to after the issues in January where we gathered enough support to ask for a meeting and I spoke to TB.

Thanks

Xviolet

The issue we have is we do not know if our data from the phase 1 GAM/IB003 is worth anything. The other trials mention the success of our trial but that alone has not created any value (so far). Whether that changes in the future we honestly don’t know and the company are not really keeping us informed. For all we know they could have a buyer lined up for the data but at the moment the mcap doesn’t show any value.

Thanks/ have a nice rest of the weekend

Thanks Max

So the other sites aren’t using our imaging. Hopefully they may start to when KS presents the results at ASCO. That would be a nice boast our revenue.

I wish the company could be more open with things like this. Everything involves us digging, asking and waiting for an answer.

Cheers Max, back to the cerveza.

Thanks

Thanks Max

Do you know if that is just at MCW or at all 58 trial sites? That’s what I can’t seem to find anywhere.

58 sites using our software is a big deal, just MCW then I would say less so.

Thanks, get back to relaxing by the pool!

So my take on all of this:

We have just raised £500k to pay FG’s wages and start another company for whatever reason.

The litigation money which was supposedly in the millions seems to be raising just tens of thousands.

Issues with method C

Have we actually sold any products yet that is creating revenue?

People said months/years ago they would give it a few more months (including me) but we still keep hoping a miracle may happen.

The only person seemingly making anything here is FG, has he managed to buy the waterpark back yet?

I bet if I come back in a year there will be the same discussions and no actual product or revenue?

Thanks

Sorry another thing from the tweet. How is it they can share the results at the ASCO26 which is only 6 months after actual completion date but we still have no results over 12 months after IB003 trial actual completion date? Why is IB003 results taking so long to be shared? It would be nice if they tweeted about IB003 and actually told shareholders the truth about what is happening.

Thanks

Thanks Max

50+ facilities involved in the trial. The question I have is how many used our imaging technology? I can’t see our technology mentioned on the clinical trial website. It would be nice if the tweets we keep getting actually state what involvement IB has had. Are they just tweets promoting MCW? More information needed I am afraid. Will this increase our revenue?

Thanks

Enjoy the break Max

Have a good weekend everybody. Hopefully some news next week

Thanks

So no rational explanation for the recent flurry of activity this week. No RNS/update. I wonder if at the AGM we could ask what they meant by the new modus operandi? As far as I can tell there has been no change, if anything it is worse as Mike doesn’t reply to emails any more.

Hopefully year end results in the next 10 days or so.

Thanks

Xviolet

You need to read the RNS’s from January and February. We own the data from the phase 1 trial (which are awaiting publication) and the EAP but are not involved in the 2 latest trials apart from doing the imaging for the Gabriel trial.

All we know is that MCW are continuing trials (using our data?) but we aren’t sponsoring them. We are all hoping our data still has some commercial value but we are being left in the dark with regards this at the moment.

I hope that helps

Thanks

Xviolet

We have nothing to do with that trial

Thanks